Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

BioCryst Pharmaceuticals Shares Outstanding 2006-2020 | BCRX

BioCryst Pharmaceuticals shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
BioCryst Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2019 116
2018 103
2017 84
2016 74
2015 73
2014 67
2013 55
2012 49
2011 45
2010 45
2009 39
2008 38
2007 33
2006 29
2005 26
BioCryst Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2020-06-30 162
2020-03-31 154
2019-12-31 116
2019-09-30 110
2019-06-30 110
2019-03-31 110
2018-12-31 103
2018-09-30 105
2018-06-30 99
2018-03-31 99
2017-12-31 84
2017-09-30 84
2017-06-30 80
2017-03-31 75
2016-12-31 74
2016-09-30 74
2016-06-30 74
2016-03-31 74
2015-12-31 73
2015-09-30 73
2015-06-30 77
2015-03-31 72
2014-12-31 67
2014-09-30 72
2014-06-30 64
2014-03-31 60
2013-12-31 55
2013-09-30 57
2013-06-30 53
2013-03-31 51
2012-12-31 49
2012-09-30 51
2012-06-30 49
2012-03-31 47
2011-12-31 45
2011-09-30 45
2011-06-30 45
2011-03-31 45
2010-12-31 45
2010-09-30 45
2010-06-30 45
2010-03-31 44
2009-12-31 39
2009-09-30 38
2009-06-30 38
2009-03-31 38
2008-12-31 38
2008-09-30 38
2008-06-30 38
2008-03-31 38
2007-12-31 33
2007-09-30 34
2007-06-30 29
2007-03-31 29
2006-12-31 29
2006-09-30 29
2006-06-30 29
2006-03-31 29
2005-12-31 26
2005-09-30 26
2005-06-30 26
2005-03-31 24
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.701B $0.049B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.719B 43.07
Takeda Pharmaceutical (TAK) Japan $58.925B 10.27
Astellas Pharma (ALPMY) Japan $30.273B 15.34
Eisai (ESALY) Japan $25.840B 21.84
UCB SA (UCBJF) Belgium $23.720B 0.00
Merck (MKGAF) Germany $17.131B 22.47
Catalent (CTLT) United States $13.600B 52.58
Grifols, S.A (GRFS) Spain $12.582B 15.38
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.650B 41.23
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.401B 46.88
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.052B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.663B 11.02
United Therapeutics (UTHR) United States $4.908B 11.35
Arrowhead Pharmaceuticals (ARWR) United States $4.379B 0.00
Evotec AG (EVTCY) Germany $4.113B 142.92
FibroGen (FGEN) United States $4.075B 0.00
Hypermarcas (HYPMY) Brazil $3.895B 14.33
ChemoCentryx (CCXI) United States $3.651B 0.00
Nektar Therapeutics (NKTR) United States $3.596B 0.00
PTC Therapeutics (PTCT) United States $3.214B 0.00
Pacira BioSciences (PCRX) United States $2.617B 68.79
Sage Therapeutics (SAGE) United States $2.606B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.454B 11.88
Cronos Group (CRON) Canada $2.026B 0.00
Xencor (XNCR) United States $1.862B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.787B 0.00
USANA Health Sciences (USNA) United States $1.762B 16.60
Revolution Medicines (RVMD) United States $1.721B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.615B 11.26
Indivior (INVVY) United States $1.573B 19.49
Corcept Therapeutics (CORT) United States $1.554B 14.31
Akebia Therapeutics (AKBA) United States $1.505B 0.00
Heron Therapeutics (HRTX) United States $1.431B 0.00
Zogenix (ZGNX) United States $1.373B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.258B 12.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Karyopharm Therapeutics (KPTI) United States $1.091B 0.00
Translate Bio (TBIO) United States $1.075B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.068B 0.00
VAXART, INC (VXRT) United States $1.005B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.966B 601.63
Esperion Therapeutics (ESPR) United States $0.937B 0.00
Tilray (TLRY) Canada $0.862B 0.00
Altimmune (ALT) United States $0.743B 0.00
Endo (ENDP) Ireland $0.742B 1.10
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
Trillium Therapeutics (TRIL) Canada $0.705B 0.00
ImmunoGen (IMGN) United States $0.674B 0.00
Collegium Pharmaceutical (COLL) United States $0.630B 0.00
Flexion Therapeutics (FLXN) United States $0.614B 0.00
Molecular Templates (MTEM) United States $0.600B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.581B 0.00
Aerie Pharmaceuticals (AERI) United States $0.577B 0.00
Siga Technologies (SIGA) United States $0.566B 60.33
Radius Health (RDUS) United States $0.564B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.536B 0.00
Ocular Therapeutix (OCUL) United States $0.519B 0.00
Ardelyx (ARDX) United States $0.511B 0.00
Innate Pharma SA (IPHYF) France $0.506B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.504B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.474B 23.66
DURECT (DRRX) United States $0.463B 0.00
TherapeuticsMD (TXMD) United States $0.433B 0.00
Organogenesis Holdings (ORGO) United States $0.429B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.348B 8.62
Harpoon Therapeutics (HARP) United States $0.326B 0.00
Redhill Biopharma (RDHL) Israel $0.324B 0.00
MEI Pharma (MEIP) United States $0.318B 0.00
OptiNose (OPTN) United States $0.304B 0.00
IMV INC (IMV) Canada $0.297B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.290B 0.00
Calithera Biosciences (CALA) United States $0.290B 0.00
Concert Pharmaceuticals (CNCE) United States $0.288B 0.00
PROFOUND MEDICL (PROF) Canada $0.286B 0.00
Rafael Holdings (RFL) United States $0.286B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.269B 0.00
Heat Biologics (HTBX) United States $0.266B 0.00
Lannett Co Inc (LCI) United States $0.240B 5.27
CASI Pharmaceuticals (CASI) United States $0.238B 0.00
KalVista Pharmaceuticals (KALV) United States $0.228B 0.00
Nivalis Therapeutics (ALPN) United States $0.219B 0.00
Nature's Sunshine Products (NATR) United States $0.217B 21.39
Aquestive Therapeutics (AQST) United States $0.216B 0.00
Taiwan Liposome (TLC) Taiwan $0.192B 0.00
Onconova Therapeutics (ONTX) United States $0.179B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.161B 7.63
Xeris Pharmaceuticals (XERS) United States $0.148B 0.00
Champions Oncology (CSBR) United States $0.120B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.118B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.112B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Biomerica (BMRA) United States $0.107B 0.00
India Globalization Capital (IGC) United States $0.105B 0.00
Otonomy (OTIC) United States $0.102B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.100B 0.00
Hemispherx BioPharma (AIM) United States $0.100B 0.00
Lipocine (LPCN) United States $0.099B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.097B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.095B 0.00
Aclaris Therapeutics (ACRS) United States $0.094B 0.00
MediWound (MDWD) Israel $0.090B 0.00
CTI BioPharma (CTIC) United States $0.089B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.088B 0.00
Addex Therapeutics (ADXN) Switzerland $0.077B 0.00
ElectroCore (ECOR) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Recro Pharma (REPH) United States $0.072B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.071B 0.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
CV Sciences (CVSI) United States $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
Sundial Growers (SNDL) Canada $0.058B 0.00
GTx (ONCT) United States $0.058B 0.00
PolarityTE (PTE) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.053B 31.64
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Natural Alternatives (NAII) United States $0.048B 0.00
IsoRay (ISR) United States $0.046B 0.00
Novan (NOVN) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
AgeX Therapeutics (AGE) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Jaguar Animal Health (JAGX) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.09
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
ProPhase Labs (PRPH) United States $0.033B 0.00
Can-Fite Biopharma (CANF) Israel $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
Vical (BBI) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 21.18
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00